Journal of Cancer Research and Therapeutics Close
 

Figure 5: Applications of OncoDynamiX in personalized medicine in glioblastoma. The figure illustrates how OncoDynamiX can assist in identification of patients for personalized medicine in Glioblastoma. Samples from patients (cancer tumor cells, cell free tumor DNA, tumors, blood) are analyzed for gene alterations, multi-omics changes, pharmacokinetics, subjected to experimental assessments for anti-cancer activities in in vitro and ex vivo studies. The information generated from these studies is integrated with the OncoDynamiX glioblastoma patient data base and processed using artificial intelligence to generate patient specific report that has recommendations for drug or drug combinations to be used for the patient

Figure 5: Applications of OncoDynamiX in personalized medicine in glioblastoma. The figure illustrates how OncoDynamiX can assist in identification of patients for personalized medicine in Glioblastoma. Samples from patients (cancer tumor cells, cell free tumor DNA, tumors, blood) are analyzed for gene alterations, multi-omics changes, pharmacokinetics, subjected to experimental assessments for anti-cancer activities in <i>in vitro</i> and <i>ex vivo</i> studies. The information generated from these studies is integrated with the OncoDynamiX glioblastoma patient data base and processed using artificial intelligence to generate patient specific report that has recommendations for drug or drug combinations to be used for the patient